This page has beta status

BMBS COST Action BM0903
Skin Barrier and Atopic Diseases (SKINBAD)

The main objective of the Action is to bundle research expertise on atopic eczema (AE) and to identify key genetic and environmental risk factors. Atopic eczema (AE) is an inflammatory skin disorder which is characterized by dry and itchy skin and a cutaneous hyperreactivity to environmental triggers. It affects at least 15% of children and 2-10% of adults and often predates the development of allergic airway diseases. Given its substantial prevalence, which has seen an enormous rise especially in industrialized nations, and the lack of cure, there is a pressing need to better understand its pathophysiology. Recent evidence from molecular genetics underscores the importance of the skin barrier genes in addition to genes promoting abnormal immunological pathways. To reveal the mechanisms by which environmental factors pursue the genetic predisposition into disease manifestation, a multi-disciplinary approach is needed with complementary experimental approaches including both in vivo studies and validated animal and in vitro models. This COST Action will bring together experts fengaged in epidemiology, genetics, clinical research and research on skin barrier and immunology.

(Descriptions are provided by the Actions directly via e-COST.)


General Information*

Chair of the Action:

Dr Sanja KEZIC (NL)

Vice Chair of the Action:

Dr Stephan WEIDINGER (DE)

Science officer of the Action:

Dr Inga DADESHIDZE

Administrative officer of the Action:

Ms Aranzazu SANCHEZ

Downloads*

Action Fact Sheet

Download AFS as .RTF

Memorandum of Understanding

Download MoU as PDF

Annual Progress Conference Report

Download Annual Progress Conference Report as PDF

Progress Report

Download Progress Report as PDF

Poster

Download Poster as PDF

Websites*

Action website:

http://www.skinbad.eu

* content provided by e-COST.
Data is synchronised once per night.

Tools

Last updated: 02 May 2011 top of page